Continued Access to Study Treatment(s), Cancers With a Mass, Bulky Tumor, Nodule, Lump, Advanced Cancer, Advanced Solid Tumors, Advanced Solid Malignancies

Explore clinical trials studying Continued Access to Study Treatment(s), Cancers With a Mass, Bulky Tumor, Nodule, Lump, Advanced Cancer, Advanced Solid Tumors, Advanced Solid Malignancies. Study availability and eligibility vary by location and protocol.

1 public trial 0 recruiting studies

Refine in advanced search Browse all conditions

Continued Access to Study Treatment(s), Cancers With a Mass, Bulky Tumor, Nodule, Lump, Advanced Cancer, Advanced Solid Tumors, Advanced Solid Malignancies trial results

Active, Not Recruiting

Ribociclib (LEE011) Rollover Study for Continued Access

NCT02934568

Conditions: Continued Access to Study Treatment(s), Cancers With a Mass, Bulky Tumor, Nodule, Lump, Advanced Cancer, Advanced Solid Tumors, Advanced Solid Malignancies
Locations: University Of Alabama At Birmingham Birmingham, Alabama, United States

Dana Farber Cancer Institute Boston, Massachusetts, United States

The Regents of the Uni of Michigan Ann Arbor, Michigan, United States

Broome Oncology Johnson City, New York, United States

View all 13 locations

View Trial Details